196JPY
6.20 BJPY
68.38 BJPY
17.21 M
About ZERIA PHARMACEUTICAL
Sector
CEO
Sachiaki Ibe
Headquarters
Tokyo
Website
Employees (FY)
1.73 K
Founded
1955
ISIN
JP3428850006
FIGI
BBG000C1WXD1
Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. It operates through the following segments: Ethical Pharmaceuticals, Consumer Healthcare, and Others. The Ethical Pharmaceuticals segment deals with the research, development, and distribution of medical drugs. The Consumer Healthcare segment manufactures, supplies, and markets self-medication over-the-counter (OTC) drugs, health foods, quasi drugs, and cosmetics. The Others segment includes insurance and real estate businesses. It also develops and distributes agricultural and industrial chemicals, and reagents. The company was founded in December 22, 1955 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4559 is 2067 JPY — it has increased by 0.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange ZERIA PHARMACEUTICAL stocks are traded under the ticker 4559.
ZERIA PHARMACEUTICAL is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
4559 stock is 0.78% volatile and has beta coefficient of 0.65. Check out the list of the most volatile stocks — is ZERIA PHARMACEUTICAL there?
ZERIA PHARMACEUTICAL revenue for the last quarter amounts to 18.37 B JPY despite the estimated figure of 18.30 B JPY. In the next quarter revenue is expected to reach 19.39 B JPY.
Yes, you can track ZERIA PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
4559 stock has risen by 2.07% compared to the previous week, the month change is a 4.48% fall, over the last year ZERIA PHARMACEUTICAL has showed a 13.41% decrease.
4559 net income for the last quarter is 3.03 B JPY, while the quarter before that showed 2.48 B JPY of net income which accounts for 21.97% change. Track more ZERIA PHARMACEUTICAL financial stats to get the full picture.
Today ZERIA PHARMACEUTICAL has the market capitalization of 90.67 B, it has decreased by 0.24% over the last week.
ZERIA PHARMACEUTICAL dividend yield was 1.78% in 2022, and payout ratio reached 28.52%. The year before the numbers were 1.84% and 39.88% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4559 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZERIA PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 1.73 K employees. See our rating of the largest employees — is ZERIA PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZERIA PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZERIA PHARMACEUTICAL stock shows the sell signal. See more of ZERIA PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZERIA PHARMACEUTICAL EBITDA is 16.87 B JPY, and current EBITDA margin is 22.17%. See more stats in ZERIA PHARMACEUTICAL financial statements.